Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To observe the relationship between the activity of rheumatoid arthritis and popliteal/epitrochlear lymph node morphology and the drainage of hand/foot superficial lymphatic vessels
Rheumatoid Arthritis patients and health participants will be recruited in our research. Then the classification of American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) 2009 will be used to identify rheumatoid arthritis patients. The measurement of disease activity are Disease Activity Score 28 (DAS28) combined with the synovitis, bone edema and bone erosion of hand and wrist detected by magnetic resonance (MR) and Doppler ultrasound (DUS).The morphology of lymph node in popliteal/epitrochlear are scanned by 3-dimensional MR and DUS. The drainage of hand/foot superficial lymphatic vessels are detected in sight of near infrared ray (NIR) with the applying of Indocyanine Green (ICG) subcutaneously. We'll conduct correlation analysis to reveal the relationship between the activity of Rheumatoid Arthritis and lymph nodes morphology and lymphatic vessels drainage.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| the patients group | 0.1ml, 5mg/ml indocyanine green(ICG) will be injected subcutaneously to aid visualization in NIR |
| |
| the health group | 0.1ml, 5mg/ml indocyanine green(ICG) will be injected subcutaneously to aid visualization in NIR |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| indocyanine green(ICG) | Drug | ICG will be injected into the dorsal of hand/foot |
|
| Measure | Description | Time Frame |
|---|---|---|
| T-initial | the time that it takes for the ICG to be detected in vessels | after the injection of ICG from the first day to the fourth day after |
| Measure | Description | Time Frame |
|---|---|---|
| S-max | the maximum ICG signal intensity observed in the target lymph node during the first day imaging session | after the injection of ICG, 1day after, 2 days after, 3 days after and 4days after |
| T-max |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Participants will be excluded when they combined with:
Not provided
Not provided
The study conducted in Shanghai, China. The participants will be recruited by advertisement in in Longhua hospital, communities and universities in Shanghai.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Qianqian Liang, Dr. | Contact | 86-021-64875390 | liangqianqiantcm@126.com | |
| Qiong Wang | Contact | 86-13671779096 | 13671779096@163.com |
| Name | Affiliation | Role |
|---|---|---|
| Yong-jun Wang, Dr. | Longhua Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Longhua Hospital, Shanghai University of TCM | Recruiting | Shanghai | Shanghai Municipality | 200032 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Peripheral blood 10ml for the analysis of cytokines,such as IL-1/6, TNF-α,VEGF-3 recepter,VEGFRC/E, et al.
the time it takes for a nodes in cubital fossa or popliteal space to achieve maximal ICG signal intensity
| after the injection of ICG, 1day after, 2 days after, 3 days after and 4days after |
| %Clearance | an assessment of ICG wash out through the lymphatics and is quantified as the percent difference of ICG signal intensity between the two ICG-NIR images from a certain region at a) S-max (first day) and b) 24 hours post ICG injection, | after the injection of ICG, 1day after, 2 days after, 3 days after and 4days after |
| Pulse | ICG pulses that pass the a certain region within 400 seconds. | after the injection of ICG, 1day after, 2 days after, 3 days after and 4days after |
| lymphatic node size | the second day after enrollment |
| lymphatic node shape | the second day after enrollment |
| lymphatic node transverse/longitudinal diameter ratio | the second day after enrollment |
| lymphatic node types of edges | the second day after enrollment |
| lymphatic node thickness of cortex/medulla | the second day after enrollment |
| lymphatic node homogeneity | the second day after enrollment |
| lymphatic node hilum | the second day after enrollment |
| lymphatic node blood flow signal | the second day after enrollment |
| Longhua Hospital, Shanghai University of TCM | Recruiting | Shanghai | 200032 | China |
|
| ID | Term |
|---|---|
| D001172 | Arthritis, Rheumatoid |
| D004108 | Dilatation, Pathologic |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D020763 | Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D007208 | Indocyanine Green |
| ID | Term |
|---|---|
| D007211 | Indoles |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided